Test Price
2,800 AED✅ Home Collection Available
CITED2 Gene Ventricular Septal Defect Type 2 Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Next‑Generation Sequencing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post‑Test Genetic Counselling and result interpretation by a Consultant Medical Geneticist.
- Insurance Verification: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This test employs Next‑Generation Sequencing (NGS) to interrogate the full coding region of the CITED2 gene, a key regulator in cardiac septation. It is intended for individuals with a suspected or family history of Ventricular Septal Defect Type 2 (VSD2), offering definitive molecular confirmation to guide cardiological and surgical management. The clinical report includes variant classification per current ACMG guidelines and a customised genetic counselling summary.
| Feature | Our Test (ISO 9001:2015) | Closest Alternative (Standard Single‑Gene Sequencing) |
|---|---|---|
| Precision | Greater than 99.9% analytical sensitivity for SNVs, indels, and CNVs within CITED2 | 95–97% sensitivity; may miss deep intronic or regulatory variants |
| Methodology | Next‑Generation Sequencing (Illumina platform, 150x mean coverage) with clinically validated bioinformatics pipeline, aligned to GRCh38 | Sanger sequencing of selected exons only |
| Turnaround Time | 3 to 4 Weeks | 6–8 Weeks (often outsourced) |
Physician Insight & Safety Protocols
“A positive CITED2 variant must be interpreted within the complete echocardiographic and family context. This test does not replace a cardiologist’s clinical evaluation; it empowers you and your care team to make informed, life‑long decisions about surveillance and potential intervention.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Maintain all prescribed therapies unless explicitly directed by your treating physician. If you are on anticoagulants, anti‑arrhythmics, or any cardiac regimen, abrupt cessation can be life‑threatening. Always coordinate test timing and medication adjustments with your cardiologist prior to sample collection.
Exclusion Criteria & Emergency Red Flags
- Active febrile illness or acute cardiac decompensation (postpone collection until clinically stable).
- Known allergy to latex or antiseptic used in venipuncture (alternative materials are available upon request).
- Emergency Red Flags: If you experience chest pain, syncope, severe shortness of breath, or palpitations with dizziness, seek immediate emergency medical attention before scheduling this test.
Patient FAQ & Clinical Guidance
1. What is the purpose of this CITED2 genetic test?
CITED2 gene testing by NGS detects pathogenic mutations causing Ventricular Septal Defect Type 2 with high accuracy. This test analyses the CITED2 gene to identify variants that disrupt normal heart septum formation, providing a molecular diagnosis for patients with isolated or syndromic VSD2. It aids in personalised risk assessment, family screening, and informed reproductive counselling.
2. How is the sample collected and what is the turnaround time?
A blood sample is collected via venipuncture; results are available within 3 to 4 weeks. You may provide whole blood, extracted DNA, or a single drop of blood on an FTA card—all options are accepted. Our temperature‑controlled cold‑chain home collection service ensures sample integrity from your doorstep to the ISO‑certified laboratory.
3. Does insurance cover this test and what is the cost?
The test costs 2,800 AED, and we verify insurance coverage directly via WhatsApp before proceeding. Many UAE insurers include genetic testing for congenital heart defects under specialist referral. Our billing team will confirm eligibility and handle pre‑approval; simply send your insurance card and doctor’s request to +971 54 548 8731.
4. Who should consider this genetic test?
This test is appropriate for individuals with a personal or family history of Ventricular Septal Defect Type 2, couples planning a family with known CITED2 variants, and patients with congenital heart disease of unclear aetiology where a genetic contribution is suspected.
UAE Regulatory & Data Privacy Adherence
Data Protection & Clinical Governance Framework
This test is performed at a DHA‑licensed facility (License No. 1143) and adheres to Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) for all genetic data handling. The laboratory operates under Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, and clinical safety and patient consent protocols follow Federal Decree‑Law No. 4 of 2016 on Medical Liability. Minors require parental or guardian consent prior to testing. The facility is ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | CITED2 Gene Ventricular Septal Defect Type 2 Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Whole Blood (Venipuncture), Extracted DNA, or FTA Card Blood Spot |
| Methodology Used | Next‑Generation Sequencing (Illumina Platform, 150x Mean Coverage, GRCh38 Alignment) |
| ICD-10-CM Code | Q21.0, Z15.09, Z82.79 |
| LOINC Code | 81677-8 |
| DHA Facility License & Laboratory Address | License No. 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians